• EZ Cap™ Human PTEN mRNA (ψUTP): Applied Protocols & Innovati

  2026-05-14

  EZ Cap™ Human PTEN mRNA (ψUTP) empowers researchers to restore PTEN function and interrogate PI3K/Akt signaling in advanced cancer models with unprecedented mRNA stability and immune evasion. This guide delivers actionable protocol enhancements, troubleshooting strategies, and comparative insights for robust, translational mRNA workflows.

• Elobixibat Hydrate: Precision IBAT Inhibition for GI Researc

  2026-05-14

  Elobixibat hydrate, a highly selective ileal bile acid transporter inhibitor, is transforming experimental and clinical workflows in gastrointestinal and metabolic research. Novel protocols—especially for bowel preparation—benefit from its unique mechanism, tolerability, and robust efficacy, as highlighted in recent multicenter trials.

• G007-LK Tankyrase 1/2 Inhibitor: Applied Use in Wnt & Cancer

  2026-05-13

  G007-LK offers robust, selective inhibition of tankyrase 1/2, enabling precise dissection of Wnt/β-catenin and Hippo signaling in APC-mutant colorectal and liver cancer models. This article delivers actionable workflows and troubleshooting insights for researchers aiming to optimize β-catenin degradation assays and tumor suppression studies.

• Micro- and Nanoplastics Increase Pulmonary Fibrosis Risk in

  2026-05-13

  This study systematically compares the pulmonary toxicity of microplastics and nanoplastics of various polymers and sizes, revealing that smaller polystyrene particles pose the highest risk for inducing pulmonary fibrosis. Mechanistic findings implicate FXR-YAP1 axis dysregulation as a key driver, providing new insight into the hazards of environmental plastic exposure and highlighting relevant molecular targets for future research.

• Glabridin-Gold(I) Complex 6d Enhances Antitumor Immunity via

  2026-05-12

  The referenced study presents a novel glabridin-gold(I) complex (6d) that synergistically modulates tumor immunogenicity and suppresses immunosuppression by targeting both TrxR and MAPK pathways. These dual effects enhance dendritic cell maturation and diminish immunosuppressive cell populations, providing a promising strategy for improving antitumor immune responses in liver cancer.

• Helper Lipids Determine Stability of saRNA-LNP Vaccine Formu

  2026-05-12

  This study dissects how the choice of helper lipid in lipid nanoparticles (LNPs) affects the storage stability and potency of self-amplifying RNA (saRNA) vaccine formulations. By systematically comparing combinations of helper and ionisable lipids, the research identifies optimal conditions for durable saRNA expression, highlighting the importance of lipid selection for translational vaccine development.

• Escitalopram in Translational Neuroscience: Selectivity, Ass

  2026-05-11

  Explore Escitalopram's (Lexapro) advanced selectivity and mechanistic depth for antidepressant research. This article offers a new perspective on SSRI assay optimization and practical evidence integration, distinguishing itself from existing protocol-oriented guides.

• Live-Dead Cell Staining Kit: Precision Cell Viability Assays

  2026-05-11

  The Live-Dead Cell Staining Kit empowers researchers to rapidly and accurately discriminate live from dead cells using Calcein-AM and Propidium Iodide dual staining. Its quantitative, dual-fluorescent approach outperforms traditional methods in flow cytometry, microscopy, and cytotoxicity testing, offering unmatched rigor and reproducibility for cell viability workflows.

• Losartan: Precision Angiotensin II Receptor Antagonism in Tr

  2026-05-10

  This thought-leadership article explores how Losartan, a selective angiotensin II receptor antagonist, is driving new strategies in cardiovascular, vascular, and tumor microenvironment research. Blending mechanistic insights with actionable guidance, we highlight key numeric findings, protocol parameters, and the evolving translational landscape—including evidence-based perspectives on vascular smooth muscle cell proliferation inhibition and emergent implications for immune modulation. Building on both foundational and recent literature, this article positions APExBIO’s Losartan as a pivotal research tool, expanding the conversation beyond classical hypertension models.

• Z-DEVD-FMK: Caspase-3 Inhibitor for Apoptosis & Neuroprotect

  2026-05-09

  Z-DEVD-FMK is a cell-permeable, irreversible caspase-3 inhibitor used for dissecting apoptosis and neuroprotection pathways. It also inhibits calpain, providing a dual mechanism relevant to traumatic brain injury studies. Evidence from in vitro and in vivo models supports its robust role in modulating cell death.

• Dorsomorphin (Compound C): Applied AMPK Inhibition in Cell M

  2026-05-08

  Dorsomorphin (Compound C) is a selective AMPK inhibitor and BMP signaling modulator, enabling precise dissection of metabolic and differentiation pathways. This article delivers actionable workflows, troubleshooting insights, and applied research strategies for leveraging Dorsomorphin in autophagy regulation and metabolic disease models.

• Losartan: Optimizing Angiotensin II Receptor Antagonist Work

  2026-05-08

  Leverage Losartan’s precise angiotensin II type 1 receptor antagonism for robust hypertension and vascular cell research. This guide details protocol enhancements, troubleshooting, and strategic insights grounded in bench-tested evidence—empowering your lab to maximize experimental reproducibility and translational relevance.

• Fenipentol (1-Phenyl-1-pentanol): Precision in Pancreatic Se

  2026-05-07

  Fenipentol, a bioactive small molecule from Ligusticum chuanxiong, is redefining gastrointestinal physiology research as a robust choleretic agent and estrogen receptor modulator. This article provides evidence-driven workflows, troubleshooting tips, and experimental insights to optimize pancreatobiliary secretion assays and support translational applications.

• PERK–JAK1–STAT3 Axis Drives ER Stress-Induced Pyroptosis in

  2026-05-07

  This study uncovers how endoplasmic reticulum stress promotes inflammatory pyroptosis in nucleus pulposus cells through the PERK/eIF2α/ATF4-mediated activation of the JAK1–STAT3 pathway. These findings establish new molecular links in intervertebral disc degeneration and identify potential intervention targets for future therapies.

• nor-Binaltorphimine dihydrochloride in Opioid Receptor Assay

  2026-05-06

  nor-Binaltorphimine dihydrochloride empowers researchers to precisely dissect κ-opioid receptor signaling, advancing pain modulation and addiction research. This guide translates recent neural circuit insights into actionable protocols, troubleshooting, and comparative strategies for high-impact opioid receptor antagonist assays.

15246 records 1/1017 page Next 12345 下5页 Last page